Apr 8, 2009 | 1
The Food and Drug Administration (FDA) has green-lighted a test that can quickly determine whether a person is infected with deadly avian flu.
The FDA yesterday approved the AVantage A/H5N1 Flu Test, made by Sunnyvale, Calif.-based Arbor Vita Corp. The nose or throat swab can detect the infection in less than 40 minutes, the agency said; previous diagnostic tests took up to four hours.
"This test is an important tool to help quickly identify emerging influenza A/H5N1 infections and reduce exposure to large populations," Daniel Schultz, director of the FDA's Center for Devices and Radiological Health, said in a statement. "The clearance of this test represents a major step toward protecting the public from the threat of pandemic flu."
Mar 2, 2009 | 2
We've known since January that most of the flu circulating this season is resistant to Tamiflu, an antiviral drug typically used against the infection. What remained a mystery was whether the resistant flu strain made people sicker than forms that respond to the treatment — and why the resistant strain surged this year, a worry for public health officials who stockpiled Tamiflu in the event of a flu pandemic stoked by avian influenza.
A study published today in the Journal of the American Medical Association indicates that Tamiflu-resistant flu does not make people any more or less sick. But researchers say they're still in dark as to why Tamiflu-resistant infections are on the rise. A whopping 98 percent of this year's circulating H1N1 flu strains are immune to Tamiflu, compared with only 12 percent during the 2007-2008 flu season.
Deadline: Jul 15 2013
Reward: $5,000 USD
SciBX: Science-Business eXchange, a joint publication from the makers
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Powered By: 